Sabar Karimah Es
Capricor Therapeutics, Inc. · Director
Sabar Karimah Es is listed in filings as Director at Capricor Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 3, 2026, including sale activity. Recent filings connect the profile to Capricor Therapeutics, Inc. (CAPR). The current snapshot covers public activity from Jan 6, 2025 to Apr 3, 2026. Reported amounts are shown as $240.9K to $1.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2M53.7k shares | SellApr 1, 2026 | $31.03 | $19.12 | |
| $2M61.3k shares | SellMar 31, 2026 | $30.17 | $19.12 |